Anti-PD1 and Anti-PDL1-Induced Hypophysitis: A Cohort Study of 17 Patients with Longitudinal Follow-Up

Anti-PD1 and Anti-PDL1-Induced Hypophysitis: A Cohort Study of 17 Patients with Longitudinal Follow-Up

Hypophysitis, secondary to programmed cell death 1 protein (PD1) and programmed cell death 1 ligand 1 (PDL1) inhibitors, were thought to be rare, with only a few studies describing more than one case with long-term follow-up. The aim of the present study was to describe the clinical, laboratory, and...

Full description

Bibliographic Details
Main Authors: Manon Levy, Juliette Abeillon, Stéphane Dalle, Souad Assaad, Françoise Borson-Chazot, Emmanuel Disse, Gérald Raverot, Christine Cugnet-Anceau
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Journal of Clinical Medicine
Subjects:
hypophysitis
adrenal insufficiency
immunotherapy
nivolumab
pembrolizumab
programmed cell death 1 protein
Online Access:https://www.mdpi.com/2077-0383/9/10/3280

Internet

https://www.mdpi.com/2077-0383/9/10/3280

Similar Items